Bacterin International Holdings (BONE) Announces Quarterly Results
Bacterin International Holdings (NASDAQ:BONE) released its earnings data on Tuesday. The company reported ($0.35) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.47) by $0.12, AR Network reports. The company had revenue of $5.60 million for the quarter, compared to the consensus estimate of $8.85 million.
Bacterin International Holdings (NASDAQ:BONE) traded up 5.23% during mid-day trading on Tuesday, hitting $4.63. 44,307 shares of the company’s stock traded hands. Bacterin International Holdings has a 52 week low of $3.70 and a 52 week high of $14.10. The stock’s 50-day moving average is $6.40 and its 200-day moving average is $6.81. The company’s market cap is $25.5 million.
Bacterin International Holdings, Inc (NASDAQ:BONE), formerly K-Kitz, Inc, develops, manufactures and markets biologics products to domestic and international markets through Bacterin’s biologics division.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.